TOREMIFENE INCREASES BONE MINERAL DENSITY IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER: INTERIM ANALYSIS OF A MULTICENTER PHASE 3 CLINICAL STUDY

PURPOSE: To evaluate the effects of toremifene on bone mineral density (BMD), a surrogate for fracture risk, in men receiving androgen deprivation therapy (ADT) for prostate cancer. MATERIALS AND METHODS: In an ongoing, multicenter, Phase 3 fracture prevention study, 1392 men ≥ 50 years old with pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Smith, MR, Malkowicz, S Bruce, Chu, F, Forrest, J, Price, D, Sieber, P, Barnette, KG, Rodriguez, D, Steiner, MS
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2007
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090686/
https://ncbi.nlm.nih.gov/pubmed/18001802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2007.08.137
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge